<DOC>
	<DOCNO>NCT00626678</DOCNO>
	<brief_summary>Description : Pemphigus vulgaris autoimmune , chronic recurrent blister disease unknown etiology affect mucosa skin patient significant morbidity mortality . The treatment back-bone base prednisolone administration . There controversy opportunity add immunosuppressive drug . For , corticosteroid spar drug . For others , disease modify drug . The purpose trial compare efficacy safety azathioprine vs. placebo new case pemphigus vulgaris treat prednisolone .</brief_summary>
	<brief_title>Azathioprine Versus Placebo Pemphigus Vulgaris Treated With Prednisolone</brief_title>
	<detailed_description>The purpose trial compare efficacy safety azathioprine vs. placebo new case pemphigus vulgaris treat prednisolone . Official Title : Randomized , Double-Blind , Placebo-Controlled Phase II Trial Azathioprine New Cases Pemphigus Vulgaris Receiving Prednisolone Randomized Double Blind Controlled Trial Azathioprine versus Placebo new case Pemphigus Vulgaris treat Prednisolone Study Type : Interventional Study Design : Treatment , Randomized , Double Blind ( Subject , Caregiver ) , Placebo Controlled , Parallel Assignment , Safety/Efficacy Study Condition Intervention Phase Pemphigus Vulgaris Drug : Azathioprine Drug : Prednisolone Other : Placebo Phase II</detailed_description>
	<mesh_term>Pemphigus</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<criteria>Lesions clinically consistent pemphigus vulgaris Diagnosis confirm histology term acantholysis within past month Positive DIF Any nursing pregnant woman Any history chronic diseases include liver disease , Chronic Renal Failure , Chronic Heart Failure Ischemic Heart Disease Present diagnosis hepatitis confirm serology elevate hepatic enzyme ; Clinically significant concurrent medical disease laboratory abnormality evidence one following : Hepatobiliary AST ALT ≥ 1.5 × upper limit normal ( ULN ) ; alkaline phosphatase ≥ 1.5 × ULN ; , total bilirubin &gt; 90 % ULN ; Renal serum creatinine &gt; 1.5 mg/dL ; , significant proteinuria &gt; 2+ urinary dip test ; Hematologic hemoglobin &lt; 11 mg/dL ; leukocytes &lt; 3.5 × 109/L ; neutrophil &lt; 1.5 × 109/L ; , platelets &lt; 100 × 109/L ; Presence anemia , leukopenia thrombocytopenia Any sign patient 's noncompliance Known hypersensitivity study drug , prednisone azathioprine Participating another clinical trial time screen enrollment</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Pemphigus Vulgaris</keyword>
	<keyword>Azathioprine</keyword>
	<keyword>Prednisone</keyword>
</DOC>